Will AI Replace Cardiologists and Turn Them Into Managers?
Although artificial intelligence is changing the role of the physician, several experts agreed that it is not making cardiologists superfluous.
Stay updated with breaking news from V Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Although artificial intelligence is changing the role of the physician, several experts agreed that it is not making cardiologists superfluous.
Study findings are encouraging, but the population was not diverse, and only one dose of atorvastatin was examined.
Results of the DICTATE-AHF randomized trial that tested starting dapagliflozin for patients hospitalized with acute heart failure confirmed the safety and benefit of this guideline-directed strategy.
'This is a population that has not gotten a lot of attention,' said an expert. Upgrading their pacemakers to a cardiac resynchronization device may be the answer for some.
Prespecified analysis of the STEP-HFpEF trial of semaglutide in people with obesity and heart failure with preserved ejection fraction showed a positive link between weight-loss amounts and outcomes.